To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Chlorproguanil/dapsone/artesunate

From Wikipedia, the free encyclopedia

Chlorproguanil/dapsone/artesunate
Combination of
ChlorproguanilAntimalarial drug
DapsoneAntibiotic
ArtesunateAntimalarial drug
Legal status
Legal status
  • Development halted
Identifiers
ChemSpider
  • none

Chlorproguanil/dapsone/artesunate (abbreviated CDA) was an experimental antimalarial treatment that entered Phase III clinical trials in 2006. Development was halted because it was associated with an increased risk of haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency.[1]

It consists of chlorproguanil, dapsone, and artesunate. (It can also be interpreted as Lapdap+artesunate.)

Studies compared this combination against artemether/lumefantrine (Coartem) and against chlorproguanil/dapsone (Lapdap). This drug was developed in collaboration between GlaxoSmithKline, UNICEF, the World Bank, Medicines for Malaria Venture and the WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), the Liverpool School of Tropical Medicine, and the London School of Hygiene and Tropical Medicine.[2]

YouTube Encyclopedic

  • 1/3
    Views:
    10 062
    1 184
    5 075
  • ANTIMALARIAL DRUGS CLASSIFICATION | PHARMACOLOGY | GPAT | NIPER | DI | PHARMACIST |
  • Malarial Drug Resistance
  • Antimalarial Drug Targets

Transcription

References

  1. ^ Van Malderen C, Van Geertruyden JP, Machevo S, González R, Bassat Q, Talisuna A, et al. (July 2012). "Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria". Malaria Journal. 11: 139. doi:10.1186/1475-2875-11-139. PMC 3393623. PMID 22546009.
  2. ^ Das P (2006). "Promising anti-malarial enters phase II studies". Lancet Infect Dis. 6 (9): 551. doi:10.1016/S1473-3099(06)70571-0.

External links

This page was last edited on 3 December 2023, at 02:01
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.